Chinese Herbal Medicine May Offer Benefits in STEMI: CTS-AMI

Treatment with tongxinluo was associated with better outcomes out to 1 year, but observers say further data are needed to see how it may fit into STEMI care in China and beyond.
Medscape Medical News

source https://www.medscape.com/viewarticle/983619?src=rss

Comments

Popular posts from this blog

New AAFP practice guideline sets blood pressure targets for adults with hypertension

RA and RA-ILD Linked to Higher Lung Cancer Risk

A Large Multicenter Prospective Study of Community-Onset Healthcare Associated Bacteremic Urinary Tract Infections in the Era of Multidrug Resistance: Even Worse than Hospital Acquired Infections?